What to expect when Radiopharm RADX reports earnings NKTR Nektar Therapeutics posts narrower Q4 2025 loss than estimates shares gain 167 percent in todays session CPAC Pacasmayo posts 7 revenue growth in Q1 2026 shares climb 181 on solid performance What Applied Mat AMAT does that builds long term value Q1 2026 Profit Exceeds Views